首页> 美国卫生研究院文献>World Journal of Gastroenterology >Differential expression of Bcl-2 and Bax during gastric ischemia-reperfusion of rats
【2h】

Differential expression of Bcl-2 and Bax during gastric ischemia-reperfusion of rats

机译:大鼠胃缺血再灌注过程中Bcl-2和Bax的差异表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIM: To investigate expression of Bcl-2 and Bax in gastric ischemia-reperfusion (GI-R) and involvement of extracellular signal-regulated kinase (ERK) 1/2 activation.METHODS: The GI-R model was established by ligature of the celiac artery for 30 min and reperfusion in Sprague-Dawley rats. Rats were assigned to groups in accordance with their evaluation period: control, 0, 0.5, 1, 3, 6, 24, 48, and 72 h. Expression and distribution of Bcl-2 and Bax proteins were analyzed by immunohistochemistry and western blotting in gastric tissue samples after sacrifice.RESULTS: Compared with controls, the percentage of positive cells and protein levels of Bcl-2 decreased in the early phases of reperfusion, reached its minimum at 1 h (P < 0.05); it then increased, reaching its peak at 24 h of reperfusion (P < 0.05). The pattern of Bax expression was opposite to that of Bcl-2. Bax expression increased after reperfusion, with its peak at 1 h of reperfusion (P < 0.05), and then it decreased gradually to a minimum at 24 h after reperfusion (P < 0.05). On the other hand, inhibition of activation of ERK1/2 induced by PD98059, a specific upstream MEK inhibitor, had significant effects on Bcl-2 and Bax in GI-R. Compared with GI-R treatment only at 3 h of reperfusion, PD98059 reduced the number of Bcl-2 positive cells (0.58% of R3h group, P < 0.05) and Bcl-2 protein level (74% of R3h group, P < 0.05) but increased the number of Bax-positive cells (1.33-fold vs R3h group, P < 0.05) and Bax protein level (1.35-fold of R3h group, P < 0.05).CONCLUSION: These results indicated that the Bcl-2 and Bax played a pivotal role in the gastric mucosal I-R injury and repair by activation of ERK1/2.
机译:目的:探讨Bcl-2和Bax在胃缺血再灌注(GI-R)中的表达以及细胞外信号调节激酶(ERK)1/2激活的参与。方法:通过结扎胃黏膜建立GI-R模型。在Sprague-Dawley大鼠中腹腔动脉进行30分钟再灌注。根据评估时间将大鼠分为组:对照组,0、0.5、1、3、6、24、48和72小时。结果:与对照组相比,Bcl-2,Bcl-2和Bax蛋白的表达和分布在免疫组化后较正常对照组明显降低。 1 h达到最小值(P <0.05);然后增加,在再灌注24小时达到峰值(P <0.05)。 Bax表达的模式与Bcl-2相反。 Bax表达在再灌注后升高,在再灌注1 h达到峰值(P <0.05),然后在再灌注24 h逐渐降低至最小值(P <0.05)。另一方面,由PD98059(一种特定的上游MEK抑制剂)诱导的ERK1 / 2激活的抑制对GI-R中的Bcl-2和Bax具有显着影响。与仅在再灌注3小时后的GI-R治疗相比,PD98059减少了Bcl-2阳性细胞的数量(R3h组的0.58%,P <0.05)和Bcl-2蛋白质水平(R3h组的74%,P <0.05) ),但增加了Bax阳性细胞数量(相对于R3h组为1.33倍,P <0.05)和Bax蛋白水平(R3h组为1.35倍,P <0.05)。结论:这些结果表明Bcl-2和Bax通过激活ERK1 / 2在胃黏膜IR损伤和修复中起关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号